Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, pharmacodynamics, safety and tolerability of PF-06882961 in Chinese adults with Type 2 diabetes mellitus; results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PF-06882961

Snippet

Sponsor: Pfizer | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2024-10-01